News | Radiation Oncology | October 22, 2021

Bipartisan oversight letters from House, Senate and caucus leaders articulate concerns with draconian cuts in the proposed Radiation Oncology Model and Medicare physician fee schedule

Bipartisan oversight letters from House, Senate and caucus leaders articulate concerns with draconian cuts in the proposed Radiation Oncology Model and Medicare physician fee schedule

Getty Images


October 22, 2021 — Eighty-five members of Congress have joined together to issue bipartisan, bicameral oversight letters to the Centers for Medicare and Medicaid Services (CMS) that call on the Agency to scale back severe cuts to radiation therapy services in the proposed Radiation Oncology Model (RO Model) and 2022 Medicare Physician Fee Schedule (MPFS). Without action from CMS, the radiation oncology community will face estimated cuts of $300 million starting January 1, 2022, jeopardizing patient access to care.

Two letters were delivered this week to CMS Administrator Chiquita Brooks-LaSure, including a letter from 67 members of the House of Representatives led by Brian Fitzpatrick (R-Pa.) and Brian Higgins (D-N.Y.) and a letter from 18 senators led by Debbie Stabenow (D-Mich.) and Richard Burr (R-N.C.). A third letter from members of the Congressional Black Caucus, the Congressional Hispanic Caucus, the Congressional Asian Pacific American Caucus and the Congressional Native American Caucus, led by Representatives Tony Cárdenas (D-Calif.) and Bobby Rush (D-Ill.) is being finalized. Of the 85 members of Congress who signed the House and Senate letters, 20 serve on key health care congressional committees.

"Now is not the time for Medicare to force cutbacks in cancer treatment," said Thomas Eichler, MD, FASTRO, Chair of ASTRO's Board of Directors. "ASTRO is overwhelmed to see so many members of Congress stand up in a bipartisan manner for radiation oncology clinics and patients. We are grateful for their leadership, and we hope President Biden's administration will agree to stop these cuts and support radiation oncology's role in ending cancer as we know it."  

The letters echo concerns from the American Society for Radiation Oncology (ASTRO) and other radiation oncology stakeholders that the payment cuts will threaten equitable access to high-quality cancer care, especially in rural and underserved communities, and will place an undue burden on medical providers still recovering from the effects of the COVID-19 public health emergency. Analyses of CMS' estimated impact data for the RO Model show that 72% of hospital outpatient departments and 62% of physician group practices that will be required to participate in the RO Model will face payment cuts.

The letters also highlight how the proposed cuts will severely impact clinics that serve predominantly racial and ethnic minority communities and could exacerbate cancer disparities affecting these patients. Specific reforms called for by these members of Congress include reducing the RO Model's excessive discount factor, not penalizing providers in the 2022 MPFS and introducing a Health Equity Achievement in Radiation Therapy (HEART) payment in the RO Model to support "wraparound" services such as patient care navigation that are designed to reduce health care disparities.

Senate Letter led by Senators Stabenow (D-Mich.) and Burr (R-N.C.) 

A group of 18 senators led by the Senate Finance Committee's longstanding supporters of radiation oncology wrote, "We are concerned that devaluing [radiation therapy] services could have chilling effects on patient access to life-saving care and urge CMS to mitigate the impact on radiation oncology providers." They also emphasized that "We recognize the valuable role radiation therapy plays in meeting the needs of oncology patients and are concerned these proposed cuts could jeopardize access to high-quality treatment." Read the letter here.

House Letter led by Representatives Higgins (D-N.Y.) and Fitzpatrick (R-Pa.)

The letter from 67 members of the House noted that, "Emerging from COVID-19, radiation oncologists are struggling to treat patients that missed screenings and now require more complex treatments for more advanced cancers," but that the extreme cuts "threaten the ability of patients, particularly underserved populations, to receive state-of-the-art care close to home." The representatives said they "remain committed to an alternative payment model for radiation therapy services that improves quality, stabilizes reimbursement, and reduces disparities, but we are concerned that these severe cuts create instability and undermine the transition to value-based payment." Read the letter here.

Caucus Letter led by Representatives Cárdenas (D-Calif.) and Rush (D-Ill.)

The letter from members of the Congressional Black Caucus, the Congressional Hispanic Caucus, the Congressional Asian Pacific American Caucus and the Congressional Native American Caucus explains that "the impact of the proposed rule could force community-based cancer clinics, many of which serve minority neighborhoods, to close their doors, lay off staff, and limit Medicare patients." It continues, "The RO Model represents a new opportunity to address health disparities in radiation therapy. Unfortunately, the proposed combined payment cuts undermine the promise of the RO Model and the chance to improve health equity," and that, "Finalizing these proposed CMS rules would undermine the Administration's ongoing efforts to eradicate cancer, and disproportionally impact vulnerable communities that already face poor access to cancer screening and care." The caucus letter will be sent to Department of Health and Human Services (HHS) Secretary Xavier Becerra as well as CMS Administrator Brooks-LaSure in the next few days.

If CMS does not make meaningful changes when the Agency issues final rules in coming weeks, ASTRO intends to work with these Congressional champions on legislation to address these payment cuts before the year ends.

For more information: www.astro.org


Related Content

News | Coronavirus (COVID-19)

February 8, 2023 — New data published in the Journal of Clinical Oncology further quantify the vast lingering impact of ...

Time February 08, 2023
arrow
News | Proton Therapy

February 7, 2023 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology, today announces ...

Time February 07, 2023
arrow
Videos | Information Technology

A discussion on macro trends and the future of medical imaging with Jef Williams, managing partner, Paragon Consulting ...

Time February 07, 2023
arrow
News | Radiation Therapy

February 6, 2023 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time February 06, 2023
arrow
News | Radiation Therapy

February 2, 2023 — DenseBreast-info.org (DBI) announced the results of the study, “Effect of an Educational Intervention ...

Time February 02, 2023
arrow
News | Radiation Therapy

February 2, 2023 — RefleXion Medical, a therapeutic oncology company, today announced the U.S. Food and Drug ...

Time February 02, 2023
arrow
News | Radiation Oncology

February 2, 2023 — The V Foundation, a top cancer research charity, has announced the establishment of a new grant ...

Time February 02, 2023
arrow
News | Radiation Therapy

February 1, 2023 — Radiotherapy is a crucial component of cancer treatment, used to shrink or destroy tumors with high ...

Time February 01, 2023
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a recap of what ITN viewers found most interesting during the month of January: 1. A Look at the Changes in 2023 ...

Time February 01, 2023
arrow
News | Radiation Therapy

January 31, 2023 — Age-based heuristics can lead to large differences in breast cancer treatment based on small ...

Time January 31, 2023
arrow
Subscribe Now